Non-clinical and first-in-human characterization of ECC5004/AZD5004, a novel once-daily, oral small-molecule GLP-1 receptor agonist.

Haggag AZ, Xu J, Butcher L, Pagnussat S, Davies G, Lundqvist S, Wang W, Van Zuydam N, Nelander K, Jha A, Yu H, Boianelli A, Lindmark B, Ollerstam A, Sun X, Wang F, Pan X, Liu H, Chen W, Xu J, Wallenius K, Zhou J

Open source

DOI: 10.1111/dom.16047
Published: 2025 Feb
Container: Diabetes, obesity & metabolism
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/dom.16047,
  title = {Non-clinical and first-in-human characterization of ECC5004/AZD5004, a novel once-daily, oral small-molecule GLP-1 receptor agonist.},
  author = {Haggag AZ and Xu J and Butcher L and Pagnussat S and Davies G and Lundqvist S and Wang W and Van Zuydam N and Nelander K and Jha A and Yu H and Boianelli A and Lindmark B and Ollerstam A and Sun X and Wang F and Pan X and Liu H and Chen W and Xu J and Wallenius K and Zhou J},
  year = {2025},
  journal = {Diabetes, obesity \& metabolism},
  doi = {10.1111/dom.16047},
  url = {https://doi.org/10.1111/dom.16047}
}

RIS

TY  - JOUR
TI  - Non-clinical and first-in-human characterization of ECC5004/AZD5004, a novel once-daily, oral small-molecule GLP-1 receptor agonist.
AU  - Haggag AZ
AU  - Xu J
AU  - Butcher L
AU  - Pagnussat S
AU  - Davies G
AU  - Lundqvist S
AU  - Wang W
AU  - Van Zuydam N
AU  - Nelander K
AU  - Jha A
AU  - Yu H
AU  - Boianelli A
AU  - Lindmark B
AU  - Ollerstam A
AU  - Sun X
AU  - Wang F
AU  - Pan X
AU  - Liu H
AU  - Chen W
AU  - Xu J
AU  - Wallenius K
AU  - Zhou J
PY  - 2025
JO  - Diabetes, obesity & metabolism
DO  - 10.1111/dom.16047
UR  - https://doi.org/10.1111/dom.16047
ER  -

APA

AZ, H., J, X., L, B., S, P., G, D., S, L., W, W., N, V. Z., K, N., A, J., H, Y., A, B., B, L., A, O., X, S., F, W., X, P., H, L., W, C., J, X., K, W., & J, Z. (2025). Non-clinical and first-in-human characterization of ECC5004/AZD5004, a novel once-daily, oral small-molecule GLP-1 receptor agonist.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.16047

Source records

pubmed · retrieved 2026-09-26T10:25:45.473Z